logo
Plus   Neg
Share
Email

Sun Pharma Launches Drizalma Sprinkle In US For Difficulty Swallowing

India- based Sun Pharmaceutical Industries Ltd. (SUNPHARMA,524715) announced Wednesday the launch of Drizalma Sprinkle (duloxetine delayed-release capsules) in the U.S. for oral use.

Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor or SNRI designed to treat various neuro-psychiatric and pain disorders in patients who have difficulty swallowing. It is estimated that the problem affects approximately 30 percent to 35 percent of long-term care residents.

The U.S. Food and Drug Administration approved Drizalma Sprinkle in July. The company noted that it is the first and only FDA-approved sprinkle formulation of delayed-release duloxetine capsules. It can be swallowed whole, sprinkled on applesauce or administered via nasogastric tube.

Drizalma Sprinkle is indicated for the treatment of major depressive disorder or MDD in adults, generalized anxiety disorder or GAD in adults and pediatric patients 7-17 years old, diabetic peripheral neuropathic pain in adults, and chronic musculoskeletal pain in adults. It is available in four dosage strengths.

Drizalma Sprinkle is the third product in Sun Pharma's US portfolio designed for individuals in long-term care after Ezallor Sprinkle (Rosuvastatin) and Kapspargo Sprinkle (metoprolol succinate) extended-release capsules.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products. SpaceX's Starship rocket prototype was damaged while undergoing pressurization testing on Wednesday evening. Video from the vicinity of SpaceX's Boca Chica test facility in Texas showed white plumes erupt from the top part of the Starship Mark 1 vehicle while it was undergoing a pressurization test. The eruption blew off the upper bulkhead high into the air.
RELATED NEWS
Follow RTT
>